Results 281 to 290 of about 989,120 (394)
Gramicidin S (GS) is a cyclic decapeptide derived from two pentapeptides. The C‐terminal thioesterase (TE) domain of gramicidin S synthetase B (GrsB) dimerizes precursor pentapeptides and cyclizes the resulting linear decapeptide. Recently, a GS variant (GS‐SA), in which a single D‐Phe was replaced by L‐Ser(Allyl), was reported via precursor‐directed ...
Sho Konno+8 more
wiley +1 more source
Caregivers take care! A literary anthology of journey toward shared care.
Kelly Landon
openalex +2 more sources
Caregiver burden in Alzheimer's disease: Case studies [PDF]
Kristin Martin‐Cook+3 more
openalex +1 more source
Symptom Onset in Classic Rett Syndrome: Analysis of Initial Clinical Severity Scale Entries
ABSTRACT Objective We aim to assess the clinical features of Rett syndrome (RTT) at registration into the National Institutes of Health–sponsored natural history study (NHS) using the Clinical Severity Scale (CSS). Introduction The CSS was established in 2000 to assess characteristics of individuals with RTT and related disorders.
Alan K. Percy+4 more
wiley +1 more source
Infection prevention and control in daycare centers-a survey of caregivers' knowledge and practices in Ogbomoso Community, Southwest Nigeria. [PDF]
Ishola RO+6 more
europepmc +1 more source
Abstract A fixed‐dose combination (FDC) tablet formulation of donepezil/memantine (10/20 mg) was developed to improve medication compliance in patients with Alzheimer's disease (AD). This study compared the pharmacokinetic (PK) characteristics and safety profiles of an FDC formulation (donepezil/memantine [10/20 mg]) and single components (SCs) of ...
Minkyu Choi+7 more
wiley +1 more source
Social determinants of health and their impact on depression in family caregivers of those with dementia: The importance of intermediary determinants. [PDF]
Cho H, Hwang Y.
europepmc +1 more source
Predicting caregiver burden and depression in Alzheimer'sdisease
Leah D. Clyburn+3 more
openalex +1 more source
Abstract A pediatric‐friendly powder for oral suspension (PfOS) of tovorafenib, a type II RAF inhibitor, was developed for patients with difficulty swallowing tablets. This open‐label, randomized, phase 1 study (QSC205140) evaluated the taste/palatability of PfOS formulations (n = 12), the relative bioavailability of the PfOS versus tablet formulation,
Yang Zhang+6 more
wiley +1 more source
Caregiver-informed meta-synthesis of caregivers' experiences with tracheostomy decision-making in pediatrics. [PDF]
Ofosu D+11 more
europepmc +1 more source